OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
In this talk, I will explore the impact of low-frequency mutations on the evolution of drug-resistant HIV, highlighting our breakthroughs with the AMPHEUS system and veSEQ pipeline for advanced genomic analyses. Our findings reveal crucial insights into the underestimated prevalence of transmitted NRTI resistance, underscoring the urgent need for enhanced surveillance in areas with high treatment failure rates.
David Bonsall, is a pioneer of pathogen genomics, leads efforts to unravel the complexities of drug resistant in HIV, leveraging cutting-edge technologies to inform global health strategies.
